These results indicate that NTZ, which targets an HBV-related viral–host protein interaction, may be a promising new therapeutic agent and a step toward a functional HBV cure https://www.cmghjournal.org/article/S2352-345X(18)30156-5/fulltext
Stef2011 has mentioned the effect of nitazoxanide many times, we would like to see his opinion on the new paper. Should we try this drug, Steff?